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1. Introduction 
Laryngeal cancers are not common1. Squamous cell carcinomas of the larynx are the 
commonest head and neck tumour in the western world. It represents approximately 1% of 
all malignancy in males 1. It’s about five times common in men than in women. The cause is 
unknown but tobacco smoking and alcohol acting synergistically increases the risk, 
radiation, asbestos and a number of occupational factors are implicated. Patients usually 
present with progressive hoarseness and difficulty in breathing, pain is an uncommon 
symptom whereas dysphagia, neck swelling, cachexia and fetor indicate advance disease. 
All patients in our series are black Africans and unfortunately they presents late. The cancer 
is confirmed by biopsy of the tumour through direct laryngoscopy under general 
anaesthesia. And tentative treatment depends on the stage of the tumour. 
2. Research methodology 
This would be 10 years retrospective studies of black African patients with laryngeal 
carcinomas carried out in University of Maiduguri Teaching Hospital Maiduguri, Federal 
Medical Centre Nguru, Federal Medical Centre, Yola. These hospitals are located in the 
North Eastern region of Nigeria, Sub-Saharan Africa. These centers also receive patients 
from neighboring countries of Niger, Chad and Cameroon. Clinical records of all patients 
with histologically confirmed laryngeal carcinoma from January 2001 – December 2010 were 
reviewed, data extracted from the records includes biodata, presenting complaints (the main 
complaints for which the patient sought medical advice), and associated complaints 
(complaints regarded as unimportant by the patient), duration of presenting complaints, 
duration of symptoms on first presentation, Social habit, physical examination findings, X-
ray of soft tissue neck, CT-Scan/MRI of the Larynx findings, the site of the lesion in the 
larynx, histopathological types, treatment offered and symptom free period after treatment 
(last entry in the case note) . Data was analyzed using Statistical Package for Social Sciences 
(SPSS) – version 15 software. Descriptive analysis done for all data; Chi square test, and 
correlation studies were applied where appropriate. Results was presented in tables and 
graphs. P – Value < 0.05 was considered significant. 
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3. Literature review 
Grossly the larynx extends from the superior border of the epiglottis to the inferior border of 
the cricoid cartilage. Anteriorly, it is related to the lingual epiglottis, the thyrohyoid 
membrane, the anterior commissure, thyroid cartilage, cricothyroid membrane and the 
anterior arch of the cricoid cartilage. The posterior relations are the posterior commissure  
the arytenoids, and the interarytenoid Space. 1. Squamous cell carcinoma of the larynx is the 
commonest head and neck cancer in the Western world. In the UK it represents 
approximately 1% of all malignancies in men. (Powell and Robin, 1983). It is about five times 
commoner in males than in females. The incidence increases with age, but the peak age of 
presentation is in the seventh decade. The cause of cancer of the larynx is not known, but 
there is an indisputable relationship between tobacco smoking and alcohol consumption, 
(US surgeon general, 1979; Hinds, Thomas and O’Reilly, 1979). Verrucous carcinoma is a 
distinct variant of well differentiated Squamous cell carcinoma. (Ackerman’s tumour). Other 
malignant tumour types include adenocarcinoma, adenoid cystic carcinoma, fibrosarcoma, 
Chondrosarcoma and lymphomas. Spread and growth depends on the site of origin of the 
primary tumour. Anatomical barriers are important factors in determining the direction and 
extend of tumour growth. 
1. Supraglottis. This comprises the larynx superior to the apex of the ventricle. Exophytic 
supraglottic cancers do not often extends to the glottic region and seldom involve the 
thyroid cartilage, Ulcerative lesions may extend down below the anterior commissure, 
Cranially supraglottic cancers extend to the vallecular and  base of the tonque, 
arytenoids cartilage and pyriform sinus is reach by deep invasion.1,2. 
2. Glottis. This comprises the vocal cords and the anterior and posterior commissures. Most 
of the tumours originates in the free margins of the vocal cords which are covered by 
squamous epithelium. Tumour may extend along the cord to the anterior commissure and 
to the muscles of the vocal cord. Fixation of the vocal cords indicate deep invasion  
3. Subglottis. This extends from the inferior border of the glottis to the lower border of the 
cricoids cartilage, tumours are rare, grow circumferentially, usually extensive before 
symptoms appear which is mainly inspiratory sridor.1,2. 
4. Clinical features 
Hoarseness is the main symptoms; 1, 2, 3. Dyspnoea and stridor are late symptoms and 
usually indicate an advanced tumour. Pain in the throat is an uncommon symptom. 
Dysphagia indicates pharyngeal invasion Neck swelling indicate extra laryngeal extension 
or lymph nodes involvement. Symptoms of anorexia, cachexia and fetor imply advanced 
disease. Indirect laryngoscopy should reveal the site and size of the lesions however because 
of difficulty in examining the subglottic and the laryngeal surface of the epiglottis. Flexible 
Fibre optic laryngoscopy helps in visualizing all part of the larynx. The neck should be 
palpated for the presence of enlarged lymph nodes. Laryngeal tumours usually metastasize 
to the upper deep cervical lymph nodes, but supraglottic tumours may cause bilateral 
nodes, and some subglottic tumours may spread to the upper mediastinal nodes. 
Palpable lymph nodes are important in determining prognosis, about one-third of patients 
with no palpable lymph nodes have histologically positive nodes, and a similar number of 
palpable nodes are histologically negative. 
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5. Investigations of patients with laryngeal cancer 
The main stay of investigation in our center was radiography. Plain X-rays soft tissue neck 
was done by the entire patient studied. Although plain X-rays soft tissue neck has no role in 
the current management of patients with carcinoma of the larynx, prevertebral soft tissue 
thickness, the epiglottis can be visualized; it is also affordable in the developing countries. 
Cost about 8USD. Computerized tomography scan(CT-Scan) which include contrast 
enhanced helical CT scanning has a high sensitivity 91% and high negative predictive values 
of 95% in detecting cartilage invasion of CA larynx7. In our survey only 15(16.1%) of our 
patients had CT scanning done. This is due to the high cost of CT scan per session. It cost 
about 300USD and most of the patients live on less than a Dollar a day. Magnetic resonance 
imaging(MRI) which has several advantages over CT-scan especially in pre- surgical 
planning can only be done by 6(6.5%) of our patients due to the cost per session of 400USD. 
The multiplanner capabilities of MRI are superior to the reformations available with the 
traditional CT-scan. MRI has been found to have a sensitivity of 89-94%, specificity 74-88% 
and a negative predictive value of 94-96% for the detection of neoplastic invasion7. Positron 
emission tomography (PET) which is critical in detection of metastasis and for follow-up of 
treated patients, but sadly such services is nonexistent in most developing nations.  
6. Treatment options 1, 2, 3, 5, 6 
The standard treatment of laryngeal carcinoma is surgery and radiotherapy in varying 
combinations. Surgery involves partial or total removal of the larynx to achieve cure, 
radiotherapy have been found to be effective in early laryngeal cancers (T1 and T2) with 
local control ranging from 70-100%. In advance laryngeal cancers (T3 and T4) post operative 
chemoradiation can achieve loco-regional control.4. 
 frequency Percentage (%) 
Partial laryngectomy and radiotherapy 6 6.5 
Total laryngectomy and radiotherapy 18 19.3 
Radiotherapy alone 32 34.4 
Chemotherapy and radiotherapy 37 39.7 
Table 1. 
 1-2 years 3-4years 5-6 years 7-8 years 9-10 years Total 
Male 30 17 6 0 3 78 
Female 6 3 0 3 0 15 
Total 36 20 6 3 3 93 
Table 2. Symptom free period 
 <1year 1-2years 3-4years 5-6years 7-8years 9-10years Total 
supraglottic 9 12 5 3 3 3 35 
glottic 0 0 6 3 0 0 9 
subglottic 3 0 6 0 0 0 9 
transglottic 13 24 3 0 0 0 40 
total 25 36 20 6 3 3 93 
Table 3. Symptom free period 
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Most patients in our series where offered synchronous therapy of chemoradiation  because 
of late presentation 54(58%) and 27(29%) presented in stage III and stage IV respectively, 
however the survival rate barely 1-2years and because of late presentation in our series most 
glottis tumour have progress to transglottic on presentation with average symptom free 
period of 3years after treatment. Overall 6(6.5%) had partial laryngectomy and post-
operative radiotherapy, 18(19.3%) had total laryngectomy and post-operative radiotherapy, 
32(34.4%) had radiotherapy alone and 37(39.7%) had chemotherapy and radiotherapy.  
The common agents used in our series include cisplatin, 5-florouracil, docetaxel and 
Adriamycin in varying combinations and administered either as neoadjuvant, adjuvant or 
concomitant chemotherapy. 
7. Discussion 
Laryngeal cancer is the most common cancer of the aerodigestive track, it accounts for 20% 
of all head and neck cancers.  The incidence of these tumours is closely correlated with 
smoking cigarettes, as head and neck tumours occur 6(six) times more often among 
cigarettes smokers then among non smokers.  
Cancer of the larynx has been found to be commoner in males, it occurs in increasing age 
with the peak incidence being in the 5th decade. 
In our study, 93 patients were surveyed with carcinoma of the larynx, 78 (83.9%) male and 
females constituted 15 (16.1%) mean age of 56 years (+ 6- 8yrs), M: F=5.2:1. 
 
Fig. 1. Age distribution 
The estimated incidence of carcinoma of the larynx in the United States is about 12,000 per 
annum while in Nigeria the incidence is estimated at 783 per annum. Squamous  
cell carcinoma is the commonest histological type; in our series it constituted 90.3% other 
were verrucous Carcinoma, 32% and Adenocarcinoma 6.5%.  Studies conducted elsewhere 
in the country by Amusa et al also showed the histological type to be predominantly 
squamous cell. 8 
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Fig. 2. Duration of symtoms 
 frequency Percentage (%) 
Squamous cell carcinoma 84 90.3 
Verrucous carcinoma 3 3.2 
Adenocarcinoma 6 6.5 
Total 93 100.0 
Table 4. Histological types 
Transglottic carcinoma was found to be the commonest with 40 (43.0%), supraglottic, 35 
(37.6%): table V.  This is in contrast to other studies in which most laryngeal cancers arise 
from the glottis, 9 this could be due to the late presentation in most of the patients with loco-
regional  involvement, (images 1, 2 and 3)   
Site N (%) 
Transglottic 40(43.0) 
Supraglottic 35(37.6) 
Glottic 9(9.7) 
Subglottic 9(9.7) 
Total 93(100.0) 
Table 5. 
Most of the patient presented with stage – III tumours, this is in agreement with most head 
and neck tumour presentation in developing countries. 
 Supraglottic Glottic Subglottic Transglottic Total 
Male 29 9 6 34 78 
Female 6 0 3 6 15 
TOTAL 35 9 9 40 93 
Table 6. Site of lesion 
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Fig. 3. Clinical stage at presentation  
There was a significant correlation between the clinical stage of the tumour at presentation 
and the site of the lesion, most patient present with stages III &IV transglottic or supraglottic 
tumour. P<0.05 (0.000). 
 
 Stage II Stage III Stage IV Total 
Supraglottc 3 20 12 35 
Glottic 9 0 0 9 
Subglottic 0 9 0 9 
Transglottic 0 25 15 40 
Total 12 54 27 93 
Table 7. Correlation between clinical stage of patient and site of lesion 
Correlation also exist between the site of the lesion and the social habit of the patients, with 
those who smoke cigarettes and drink alcohol presenting more with glottis  tumours             
P< 0.05(0.00) This could be due to the synergistic effect of cigarette smoking and alcohol on 
head and neck tumours. 
 
 Supraglottic Glottic Subglottic Transglottic Total 
smoke 12 0 0 15 27 
alcohol 0 0 0 3 3 
Smoke and alcohol 3 6 3 3 15 
None 20 3 6 19 48 
Total 35 9 9 40 93 
P<0.05(0.000) 
Table 8. Correlation between social habit of patients and site of lesion  
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Site of lesion Stage II Stage III Stage IV Total 
Supraglottic 3 20 12 35 
Glottic 9 0 0 9 
Subglottic 0 9 0 9 
Transglottic 0 25 15 40 
Total 12 54 27 93 
And the site of lesion P<0.05 (0.000) 
Table 9. Correlation between the clinical stages of the tumour 
8. Conclusion 
In conclusion black African patients in our study typically present late which accounts for 
the higher number of transglottic and supraglottic cancers. Among some of the reasons for 
late presentations are lack of affordability and accessibility by most patients to tertiary 
health facility in developing countries like Nigeria. The national health insurance scheme 
covers less than 10% of the population of 150million Nigerians thus living the majority to 
pay an exorbitant fee for health care services. Another reason is the absence of radiotherapy 
centers in most tertiary health facility in developing countries such that patient have to 
travel a long distance with their relatives to access such services further increasing the cost 
of treatment and delay before presentation. 
Finally there is a need to educate the general public and especially health care providers to 
promptly refer patients with hoarseness of more than 2 weeks duration for direct 
laryngoscopy and biopsy by an otolaryngologist. 
Most countries in sub-Saharan Africa are now emerging democracies, and thus the 
challenges of infrastructural development and health care reforms are central to effective 
governance. 
In Nigeria for instance in the last ten years about 20 tertiary health centers are established by 
the governments and the existing teaching hospitals are completely overhauled to improve 
service delivery particularly in the area of cancer management, new radiotherapy centers 
are established to complement the old existing ones, which are also upgraded. Also most 
states in Nigeria have upgraded some of their secondary health centers to specialist tertiary 
health care centers while the existing secondary health centers are renovated and equipped 
with modern facilities. Personnel are also trained to reduce the doctor to patient’s ratio and 
also to manage the new and modern equipments, for example a decade ago there are about 
30 trained ENT surgeons practicing in Nigeria but with better facilities and more training 
centers there are now about 350 ENT surgeons in Nigeria. Patients are now seeking prompt 
medical consultations to find solutions to their health problems, this is partly made possible 
by continuous health education through both electronic and prints media. However there 
are some problems militating against improved health care services particularly in cancer 
management, these are, paucity of clinical pathologist, lack of regular maintenance of 
medical hardware’s partly because of lack of spare parts and the technical knowhow in  
sub-Saharan Africa. 
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The future direction in head and neck cancer management in Africa is promising because 
both governments and non-governmental organizations are establishing various cancer 
treatment centers to complement the existing centers. Through the non-governmental 
organizations doctors and other health care workers all over the world are visiting and 
assisting African patients from all field of medical specialty. 
 
 
Picture 1. Gluck Sorenson incision and flap Secured to the chin, with tracheostomy  
Pre-operatively done to relieve airway obstruction. 
 
 
Picture 2. A complete surgical specimen of the larynx with hyoid bone. 
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Picture 3. A Longitudinal cut through laryngeal specimen showing the 
Transglottic spread of the tumour 
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